Business · 14/08/2014

FDA Corrects Final Rule on Postmarketing Safety Reports for Human Drug and Biological Products

The Food and Drug Administration (FDA) is correcting a final rule that was published in 2014, which required the submission of postmarketing safety reports for human drugs and biological products in an electronic format. The corrections address incorrect information regarding the availability of ICH data elements and the impact on small entities.